Cancer cells and MDSCs express IDO, which activates protein kinase 2 (PK2) and inhibit mammalian target of rapamycin (mTOR) signal, resulting in the hindrance of T cell proliferation and survival [38, 42]. This evidence concerns the gene IDO1 and cancer.